Skip to main content
Top
Published in: Journal of Nuclear Cardiology 5/2015

01-10-2015 | Debate Article

Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques

Authors: Federico Caobelli, MD, FEBNM, Frank M. Bengel, MD, FAHA

Published in: Journal of Nuclear Cardiology | Issue 5/2015

Login to get access

Excerpt

The left ventricular (LV) dysfunction exhibited by the patient is of equivocal origin. Nuclear imaging provides a very well-validated, versatile series of tests for proper diagnosis of disease pathophysiology, with the added, equally well established benefit of incremental information on patient prognosis and guidance towards optimal therapy (Table 1). In this case, the patient should first undergo a perfusion test, to identify or rule out an ischemic origin of LV dysfunction, and to distinguish between ischemia and myocardial infarction. If a fixed perfusion defect is present, a subsequent viability study using metabolic tracers can assist in selecting the appropriate treatment course. In addition, independent of ischemic or nonischemic origin, complementary assessment of absolute myocardial blood flow can identify severity of global microcirculatory dysfunction as a prognostic marker, and imaging of myocardial sympathetic innervation may be employed to determine individual risk of arrhythmia or heart failure progression.
Table 1
Approaches for nuclear imaging in heart failure
Target mechanism
Method
Clinical goal
LV function, geometry, dyssynchrony
ECG-gated SPECT & PET (any tracer)
Define HF severity, determine prognosis (guide therapy)
Perfusion (relative)
SPECT (201Tl, 99mTc-sestamibi, 99mTc-tetrofosmin)
Identify ischemia, determine need for revascularization
PET (13NH3, 82Rb, 18F-Flurpiridaz)
Absolute flow (flow reserve)
PET (15H2O,13NH3, 82Rb, 18F-Flurpiridaz)
Identify global disease burden; guide/monitor therapy
(SPECT—work in progress)
Viability
PET (18F-FDG)
Determine revascularization benefit
SPECT (201Tl, 99mTc-agents)
Sympathetic innervation
SPECT (123MIBG)
Risk assessment, guide anti-arrhythmic therapy
PET (various tracers)
Inflammation
PET (18F-FDG, with preparation)
Determine cardiac (sarcoid) involvement (noninvasive biopsy), guide therapy
SPECT (111In-/99mTc-WBCs)
Amyloid deposit
PET (11C-PIB, 18F-amyloid markers)
Determine cardiac involvement (noninvasive biopsy), guide therapy
SPECT (99mTc-MDP)
LV, left ventricular; ECG, electrocardiogram; HF, heart failure; FDG, fluorodeoxyglucose; WBC, white blood cell; MDP, methylendiphosphonate)
Literature
1.
go back to reference Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease. Clinical perspective: A bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5:700-7.CrossRefPubMed Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease. Clinical perspective: A bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5:700-7.CrossRefPubMed
2.
go back to reference Sharma P, Patel CD, Karunanithi S. Comparative accuracy of CT attenuation-corrected and non-attenuation-corrected SPECT myocardial perfusion imaging. Clin Nucl Med 2012;37:332-8.CrossRefPubMed Sharma P, Patel CD, Karunanithi S. Comparative accuracy of CT attenuation-corrected and non-attenuation-corrected SPECT myocardial perfusion imaging. Clin Nucl Med 2012;37:332-8.CrossRefPubMed
3.
go back to reference Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Assessment of patients with suspected coronary artery disease. J Nucl Med 2006;47:74-82.PubMed Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW, Thomson LE, et al. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Assessment of patients with suspected coronary artery disease. J Nucl Med 2006;47:74-82.PubMed
4.
go back to reference Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman D. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMed Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman D. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMed
5.
go back to reference Tio RA, Dabeshlim A, Siebelink HM, De Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.CrossRefPubMed Tio RA, Dabeshlim A, Siebelink HM, De Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.CrossRefPubMed
6.
go back to reference Mc Ardle BA, Dowsley TF, deKemp RA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol 2012;60:1828-37.CrossRefPubMed Mc Ardle BA, Dowsley TF, deKemp RA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol 2012;60:1828-37.CrossRefPubMed
7.
go back to reference Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858-68.PubMedCentralCrossRefPubMed Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858-68.PubMedCentralCrossRefPubMed
8.
go back to reference Bengel FM. Leaving relativity behind: Quantitative clinical perfusion imaging. J Am Coll Cardiol 2011;58:749-51.CrossRefPubMed Bengel FM. Leaving relativity behind: Quantitative clinical perfusion imaging. J Am Coll Cardiol 2011;58:749-51.CrossRefPubMed
9.
go back to reference Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.CrossRefPubMed Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.CrossRefPubMed
10.
go back to reference Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131:19-27.CrossRefPubMed Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131:19-27.CrossRefPubMed
11.
go back to reference Wells RG, Timmins R, Klein R, Lockwood J, Marvin B, Wei L, et al. Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model. J Nucl Med 2014;55:1685-9.CrossRefPubMed Wells RG, Timmins R, Klein R, Lockwood J, Marvin B, Wei L, et al. Dynamic SPECT measurement of absolute myocardial blood flow in a porcine model. J Nucl Med 2014;55:1685-9.CrossRefPubMed
12.
go back to reference Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.CrossRefPubMed Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.CrossRefPubMed
13.
go back to reference Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.CrossRefPubMed Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.CrossRefPubMed
14.
go back to reference Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.CrossRefPubMed Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12.CrossRefPubMed
15.
go back to reference Abraham A, Nichol G, Williams KA, Guo A, Garrard L, Davies RA, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: The Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 2010;51:567-74.CrossRefPubMed Abraham A, Nichol G, Williams KA, Guo A, Garrard L, Davies RA, et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: The Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 2010;51:567-74.CrossRefPubMed
16.
go back to reference Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.CrossRefPubMed Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212-21.CrossRefPubMed
17.
go back to reference Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, et al. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 2011;4:87-93.CrossRefPubMed Gerson MC, Caldwell JH, Ananthasubramaniam K, Clements IP, Henzlova MJ, Amanullah A, et al. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients. Circ Cardiovasc Imaging 2011;4:87-93.CrossRefPubMed
18.
go back to reference Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141-9.PubMedCentralCrossRefPubMed Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 2014;63:141-9.PubMedCentralCrossRefPubMed
19.
20.
go back to reference Bengel FM. The non-invasive biopsy: Molecular imaging for the detection of cardiac involvement in systemic disease. Eur Heart J Cardiovasc Imaging 2014;15:1299-300.CrossRefPubMed Bengel FM. The non-invasive biopsy: Molecular imaging for the detection of cardiac involvement in systemic disease. Eur Heart J Cardiovasc Imaging 2014;15:1299-300.CrossRefPubMed
Metadata
Title
Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques
Authors
Federico Caobelli, MD, FEBNM
Frank M. Bengel, MD, FAHA
Publication date
01-10-2015
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 5/2015
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0128-1

Other articles of this Issue 5/2015

Journal of Nuclear Cardiology 5/2015 Go to the issue

Nuclear Cardiology in the Literature

A selection of recent, original research papers